DUBLIN — Medtronic plc, the global leader in medical technology, today announced it has received CE Mark for its new Guardian Connect mobile continuous glucose monitoring system for people with diabetes using insulin injection therapy. Guardian Connect is the first smartphone-enabled CGM system from Medtronic to receive CE Mark and further demonstrates the company’s intent …read more.